GPC3 and hepatocellular carcinoma: In 13 HCC patients, the detection rates of AFP, GPC3, EpCAM, and ALB mRNA were 15.4% (2/13), 7.7% (1/13), 15.4% (2/13) and 46.2% (6/13), respectively (Figure 5).